Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.49 +0.01 (+0.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Return on Assets [ROA] (2011 - 2026)

Updated

Oramed Pharmaceuticals' Return on Assets [ROA] was 54.77% in Q2 2026, up 70.44 percentage points from -15.67% a year earlier and up 10.76 percentage points from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Oramed Pharmaceuticals came in at 33.16%, up 43.32 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +4.12 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -10.17% in FY2024 (-13.06 pp), 2.89% in FY2023 (+25.14 pp), -22.25% in FY2022 (-30.26 pp) and 8.01% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q4 2013.
  • Compared with a year earlier, Return on Assets [ROA] has increased for four straight quarters, with an average year-over-year change of +17.78 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 70.44 percentage points); the worst was Q2 2025 (a drop of 26.59 percentage points).
  • Per Business Quant data, ORMP's Return on Assets [ROA] in the three quarters before Q2 2026 was 44.01% (Q1 2026), 28.37% (Q4 2025) and 22.93% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Oramed Pharmaceuticals 185.50 Mn 185.50 Mn - 54.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.77%
Mar 31, 2026 44.01%
Dec 31, 2025 28.37%
Sep 30, 2025 22.93%
Jun 30, 2025 -15.67%
Mar 31, 2025 -18.68%
Dec 31, 2024 -11.93%
Sep 30, 2024 2.76%
Jun 30, 2024 10.92%
Mar 31, 2024 5.03%
Dec 31, 2023 2.45%
Sep 30, 2023 -10.57%
Jun 30, 2023 -15.46%
Mar 31, 2023 -21.27%
Dec 31, 2022 -25.32%
Sep 30, 2022 -19.26%
Jun 30, 2022 0.97%
Mar 31, 2022 4.86%
Nov 30, 2019 47.50%
Aug 31, 2019 37.22%
API Access

Oramed Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ORMP&period=max&api_key=YOUR_API_KEY